*Some Market data delayed by 15 mins.

Journey Medical Corporation Common Stock

Symbol: DERM (NASDAQ)
7.20 ▼ (-0.41%) -0.030

Company Description:
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Key Stats
  • Today's Open: $7.22
  • Today's High: $7.445
  • Today's Low: $7.17
  • Today's Volume: 145.31K
  • Yesterday Close: $7.23
  • Yesterday High: $7.45
  • Yesterday Low: $7.07
  • Yesterday Volume: 161.56K
  • Last Min Volume: 199
  • Last Min High: $7.2
  • Last Min Low: $7.2
  • Last Min VWAP: $7.2
Company Profile
  • Name: Journey Medical Corporation Common Stock
  • Website: https://www.journeymedicalcorp.com
  • Listed Date: 2021-11-12
  • Location: SCOTTSDALE, AZ
  • Market Status: Active
  • CIK Number: 0001867066
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $190.22M
  • Round Lot: 100
  • Outstanding Shares: 26.31M
  • Asset Type: CS
RECENT FILINGS FOR DERM
Filing Date Filing Type Format
2025-08-28 8-K View
2025-08-28 424B3 View
2025-08-26 4 View
2025-08-14 SCHEDULE 13G/A View
2025-08-12 10-Q View
2025-08-12 8-K View
2025-08-07 4 View
2025-08-07 4 View
2025-08-07 4 View
2025-08-07 4 View
2025-08-07 4 View
2025-07-14 8-K View
2025-07-07 4 View
2025-07-07 4 View
2025-07-07 4 View
2025-07-07 4 View
2025-07-07 4 View
2025-06-26 8-K View
2025-06-24 8-K View
2025-06-20 4 View
Latest News on DERM

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.